Vivani Medical Inc. (VANI NASDAQ) stock market data APIs
$1.2716
0.01(0.8%)
as of July 1, 2025
Try our APIs with
free plan!
Vivani Medical Inc. Financial Data Overview
Price chart is built with
Anychart
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.
Prev. Close
1.2716
Open
1.2801
High
1.3404
Low
1.2716
52 wk Range
0.905-1.5
Market Cap
76 425 K
Shares Outstanding
59 244 K
EPS
-0.1054
Beta
3.334
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vivani Medical Inc. data using free add-ons & libraries
Get Vivani Medical Inc. Fundamental Data
Vivani Medical Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -24 604 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.12
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vivani Medical Inc. News
New
Vivani Medical Appoints Anthony Baldor To Succeed Brigid Makes As CFO
(RTTNews) - Vivani Medical, Inc. (VANI), a clinical-stage biopharmaceutical company, announced Wednesday the appointment of Anthony Baldor as Chief Financial Officer. Baldor succeeds Brigid Makes, wh...
Vivani Medical appoints Anthony Baldor as CFO
* Vivani Medical (NASDAQ:VANI [https://seekingalpha.com/symbol/VANI]) announced on Wednesday the appointment of Anthony Baldor as chief financial officer (CFO [https://seekingalpha.com/symbol/CFO])....
Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit
Vivani Medical, Inc. VANI recently announced the filing of a Form 10 registration statement with the U.S. Securities and Exchange Commission (“SEC”), marking the first formal step toward spinning ...
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
Transaction is anticipated to be completed in third quarter 2025 Planned Cortigent Nasdaq listing intended to drive value for Vivani and Cortigent stockholders Cortigent is developing the Orion® Vi...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
